Open to opportunities

SzeMing Lee

@szeminglee

Finance director with 20 years leading corporate finance, M&A, investment evaluation, and multi-entity governance across regulated markets.

Singapore

Message

What I'm looking for

I’m looking to build finance function from ground up, lead finance transformation and strategic decisions—driving governance, capital allocation, M&A execution, and investment evaluation—while building high-performing teams across multi-entity environments.

I’m a finance leader with 20 years of international experience spanning corporate finance, M&A execution, investment evaluation, and multi-entity financial governance. I’ve led end-to-end deal management and portfolio oversight, and I partner with senior leadership and boards to translate complex financials into clear decision analytics.

Most recently as Corporate Finance Director at UNABIZ Holdings, I drove governance across 7 entities in 5 countries, built consolidated reporting and early-warning liquidity monitoring, and managed annual budgeting, reforecasting, and month-end reporting for board and investor materials. I also led capital raising (Series B2 and Pre-Series C totaling US$36M) and digitized finance processes with pipeline tracking dashboards to improve forecast transparency and decision speed.

Experience

Work history, roles, and key accomplishments

Corporate Finance Director

Unabiz Holdings Pte Ltd

Jan 2022 - Jan 2026 (4 years)

Drove financial governance across 7 entities in 5 countries, designing consolidated P&L and cash-flow frameworks and implementing early-warning liquidity monitoring to support capital allocation. Managed budgeting and month-end reporting for board/investor audiences and led capital raising for Series B2 and Pre-Series C rounds totaling $36M, from business cases and valuation modeling through due d

Corporate Finance Financial Governance Consolidation Reporting Budgeting Liquidity Monitoring Financial Modelling Capital Raising Due Diligence

Finance & Corporate Dev Lead

VetCell Therapeutics

Jan 2015 - Jan 2022 (7 years)

Executed end-to-end M&A transactions, including VetCell’s acquisition by US-listed PrimeGen (2016) and a subsequent HKEx-listed investor transaction (2022), covering valuation, due diligence, structuring, negotiations, and legal documentation. Built finance/accounting/legal/HR functions from zero to 15+ staff, maintained IFRS and US GAAP governance across entities, led audit interactions, and impl

Due Diligence Deal Structuring Negotiation IFRS Internal Controls Audit Management ERP Implementation Team Leadership

Business Development Director

Harmony Medical Inc

Jan 2013 - Jan 2021 (8 years)

Monitored portfolio company performance and evaluated early-stage investment proposals, translating business plans and financial projections into risk mitigation and value-creation recommendations. Led healthcare and med-tech transaction processes and governance, including joint venture setups, product registrations, and regional expansion across China and Hong Kong.

Portfolio Analysis Valuation Deal Structuring Stakeholder Management Regulatory Coordination

GE Finance & Audit Roles

General Electric Company

Jan 2004 - Jan 2011 (7 years)

Performed multiple finance and investment roles across GE Capital (Healthcare Financial Services), GE Corporate, and GE Plastics, including executing 15 debt transactions with $220M NEAs and managing $180M debt portfolio investments. Led internal audit and control reviews across entities, including automated derivatives technical review covering $32B+ notional exposure and streamlined valuation co

Debt Transactions Financial Modeling Internal Audit Financial Control GAAP Compliance Regulatory Compliance Derivatives Valuation Controls Portfolio Management